PP
PDT Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-6,058
| Closed | -$4.32M | – | 837 |
|
2024
Q4 | $4.32M | Buy |
6,058
+3,057
| +102% | +$2.18M | 0.38% | 60 |
|
2024
Q3 | $3.15M | Buy |
3,001
+1
| +0% | +$1.05K | 0.28% | 105 |
|
2024
Q2 | $3.15M | Buy |
+3,000
| New | +$3.15M | 0.3% | 99 |
|
2023
Q4 | – | Sell |
-2,301
| Closed | -$1.89M | – | 651 |
|
2023
Q3 | $1.89M | Buy |
+2,301
| New | +$1.89M | 0.24% | 139 |
|
2022
Q1 | – | Sell |
-500
| Closed | -$316K | – | 1080 |
|
2021
Q4 | $316K | Buy |
+500
| New | +$316K | 0.02% | 653 |
|
2021
Q2 | – | Sell |
-502
| Closed | -$238K | – | 935 |
|
2021
Q1 | $238K | Buy |
+502
| New | +$238K | 0.02% | 665 |
|
2020
Q3 | – | Sell |
-13,304
| Closed | -$8.3M | – | 837 |
|
2020
Q2 | $8.3M | Sell |
13,304
-17,096
| -56% | -$10.7M | 0.56% | 32 |
|
2020
Q1 | $14.8M | Buy |
30,400
+1,399
| +5% | +$683K | 1.18% | 6 |
|
2019
Q4 | $10.9M | Sell |
29,001
-5,404
| -16% | -$2.03M | 0.67% | 13 |
|
2019
Q3 | $9.54M | Buy |
34,405
+6,398
| +23% | +$1.77M | 0.57% | 46 |
|
2019
Q2 | $8.77M | Buy |
28,007
+3
| +0% | +$939 | 0.52% | 76 |
|
2019
Q1 | $11.5M | Sell |
28,004
-10
| -0% | -$4.11K | 0.65% | 30 |
|
2018
Q4 | $10.5M | Buy |
28,014
+13
| +0% | +$4.86K | 0.58% | 40 |
|
2018
Q3 | $11.3M | Buy |
+28,001
| New | +$11.3M | 0.47% | 56 |
|
2015
Q4 | – | Sell |
-40,498
| Closed | -$18.8M | – | 838 |
|
2015
Q3 | $18.8M | Buy |
+40,498
| New | +$18.8M | 0.42% | 48 |
|
2015
Q2 | – | Sell |
-31,740
| Closed | -$14.3M | – | 1589 |
|
2015
Q1 | $14.3M | Buy |
+31,740
| New | +$14.3M | 0.36% | 48 |
|
2014
Q4 | – | Sell |
-64,420
| Closed | -$23.2M | – | 1004 |
|
2014
Q3 | $23.2M | Sell |
64,420
-48,118
| -43% | -$17.3M | 0.59% | 28 |
|
2014
Q2 | $31.8M | Buy |
112,538
+45,854
| +69% | +$13M | 0.85% | 9 |
|
2014
Q1 | $20M | Buy |
+66,684
| New | +$20M | 0.48% | 37 |
|
2013
Q4 | – | Sell |
-13,954
| Closed | -$4.37M | – | 1060 |
|
2013
Q3 | $4.37M | Buy |
+13,954
| New | +$4.37M | 0.12% | 217 |
|